A simple supplement could be a safe and cost-effective way of reducing heart disease in individuals born with a low birth weight, suggests research from the University of Cambridge. The study, carried out in rats, also raises the possibility of developing a blood test to indicate how much damage there is in the aortas of these individuals.
The University of Cambridge is to receive £15 million over five years from the Biotechnology and Biological Sciences Research Council (BBSRC) to support the training and development of 150 PhD students. Students will be trained in world-class bioscience that will help boost the economy and build on UK strengths in areas such as agriculture, food, industrial biotechnology, bioenergy and health.
Children with type 1 diabetes have been able to use pioneering artificial pancreas technology, developed at the University of Cambridge, for the first time overnight at home without the supervision of researchers.
New study’s findings overturn theory of personal risk preference as a ‘stable trait’, and show that real source of instability in risk behaviour “lurks deep in the physiology of traders and investors”.
Researchers believe the gene could be a useful therapeutic target for treating obesity and type 2 diabetes
Scientists hopeful discovery will provide a biological target for drug therapy.
Protein highlights ‘ideal mechanism’ for development of new therapies to fight obesity.
Cambridge research funded by the health charity Diabetes UK has for the first time successfully demonstrated the potential of an ‘artificial pancreas’ in preventing night-time hypoglycaemia in adults with Type 1 diabetes.
Research provides new insight into why poor diet during pregnancy negatively affects offspring’s long term health.
© 2025 University of Cambridge